Abbott Laboratories
ABT | NYSE
$108.71
+$2.51 (+2.36%)
Nov 2, 2026, 12:09 PM ET · Market open
TTM Period Ending | Q3 2026 Sep 30, 2026 | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 48.23B | 46.59B | 45.13B | 44.33B | 43.84B | 43.11B | 42.34B | 41.95B | 41.22B | 40.73B | 40.33B | 40.11B | 39.96B | 40.23B | 41.51B | 43.65B | 45.03B | 45.55B | 44.51B | 43.08B | 42.31B | 40.23B | 37.34B |
Cost of Revenue | 20.68B | 20.12B | 19.69B | 19.72B | 20.18B | 20.35B | 20.57B | 20.6B | 20.21B | 20.11B | 20.07B | 20.07B | 20.2B | 20.3B | 20.75B | 21.33B | 21.47B | 21.14B | 20.5B | 19.86B | 19.62B | 19.27B | 18.27B |
Gross Profit | 27.55B | 26.46B | 25.45B | 24.61B | 23.67B | 22.76B | 21.77B | 21.35B | 21.01B | 20.62B | 20.26B | 20.04B | 19.76B | 19.93B | 20.76B | 22.32B | 23.56B | 24.41B | 24.01B | 23.21B | 22.69B | 20.96B | 19.07B |
Operating Income | 7.35B | 7.93B | 8.2B | 8.05B | 7.79B | 7.55B | 7.18B | 6.88B | 6.75B | 6.61B | 6.44B | 6.45B | 6.03B | 6.06B | 6.88B | 8.36B | 9.37B | 10.29B | 9.95B | 9.2B | 9.17B | 8B | 6.65B |
Interest Income | 184M | 261M | 332M | 308M | 321M | 335M | 346M | 344M | 342M | 348M | 364M | 385M | 384M | 342M | 270M | 183M | 106M | 61M | 46M | 43M | 41M | 41M | 39M |
Pretax Income | 6.56B | 7.51B | 8.14B | 8.47B | 8.14B | 7.9B | 7.36B | 7.01B | 6.78B | 6.51B | 6.54B | 6.66B | 6.19B | 6.28B | 6.99B | 8.31B | 9.31B | 10.05B | 9.04B | 8.21B | 8.27B | 7.2B | 6.38B |
Net Income | 4.7B | 5.43B | 6.28B | 6.52B | 13.98B | 13.98B | 13.5B | 13.4B | 5.77B | 5.56B | 5.63B | 5.72B | 5.16B | 5.16B | 5.8B | 6.93B | 7.89B | 8.55B | 7.73B | 7.07B | 7.24B | 6.38B | 5.72B |
Selling & General & Admin | 14.57B | 13.48B | 12.59B | 12.38B | 12.13B | 11.92B | 11.75B | 11.65B | 11.48B | 11.28B | 11.08B | 10.87B | 11.01B | 11.04B | 11.07B | 11.11B | 11.27B | 11.31B | 11.28B | 11.28B | 10.85B | 10.38B | 9.93B |
Research & Development | 3.28B | 3.16B | 3.01B | 2.96B | 2.95B | 2.88B | 2.84B | 2.82B | 2.78B | 2.73B | 2.74B | 2.72B | 2.72B | 2.84B | 2.81B | 2.85B | 2.92B | 2.81B | 2.78B | 2.74B | 2.68B | 2.59B | 2.5B |
Other Expenses | 2.34B | 1.92B | 1.68B | 1.25B | 831M | 411M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 20.2B | 18.56B | 17.27B | 16.59B | 15.91B | 15.21B | 14.59B | 14.47B | 14.26B | 14.01B | 13.82B | 13.59B | 13.73B | 13.88B | 13.88B | 13.96B | 14.19B | 14.13B | 14.06B | 14.01B | 13.53B | 12.96B | 12.43B |
Interest Expense | 890M | 637M | 459M | 419M | 451M | 573M | 620M | 603M | 686M | 668M | 653M | 698M | 627M | 535M | 467M | 315M | 240M | 303M | 354M | 410M | 435M | 442M | 467M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 22M | 22M | 22M |
Cost & Expenses | 40.88B | 38.65B | 36.93B | 36.28B | 36.06B | 35.56B | 35.16B | 35.07B | 34.46B | 34.11B | 33.89B | 33.66B | 33.93B | 34.17B | 34.63B | 35.29B | 35.66B | 35.26B | 34.56B | 33.88B | 33.14B | 32.23B | 30.69B |
Income Tax Expense | 1.86B | 2.09B | 1.86B | 1.94B | -5.84B | -6.08B | -6.15B | -6.39B | 1.01B | 952M | 908M | 941M | 1.03B | 1.12B | 1.19B | 1.37B | 1.42B | 1.49B | 1.32B | 1.14B | 1.03B | 828M | 658M |
Shares Outstanding (Basic) | 1.74B | 1.74B | 1.75B | 1.75B | 1.75B | 1.74B | 1.75B | 1.73B | 1.73B | 1.73B | 1.73B | 1.73B | 1.74B | 1.74B | 1.74B | 1.74B | 1.74B | 1.75B | 1.75B | 1.76B | 1.77B | 1.77B | 1.78B |
Shares Outstanding (Diluted) | 1.74B | 1.74B | 1.75B | 1.75B | 1.75B | 1.75B | 1.75B | 1.75B | 1.75B | 1.75B | 1.75B | 1.75B | 1.75B | 1.75B | 1.75B | 1.75B | 1.76B | 1.77B | 1.78B | 1.78B | 1.79B | 1.79B | 1.79B |
EPS (Basic) | 2.70 | 3.11 | 3.60 | 3.74 | 8.05 | 8.06 | 7.79 | 7.74 | 3.33 | 3.21 | 3.25 | 3.30 | 2.97 | 2.96 | 3.32 | 3.96 | 4.50 | 4.87 | 4.39 | 4 | 4.09 | 3.60 | 3.23 |
EPS (Diluted) | 2.70 | 3.11 | 3.59 | 3.73 | 7.98 | 7.98 | 7.71 | 7.65 | 3.29 | 3.17 | 3.21 | 3.26 | 2.94 | 2.93 | 3.29 | 3.92 | 4.45 | 4.81 | 4.33 | 3.95 | 4.04 | 3.56 | 3.20 |
EBITDA | 9.71B | 11.33B | 11.58B | 12B | 11.8B | 11.61B | 11.14B | 10.83B | 10.69B | 10.42B | 10.43B | 10.61B | 10.05B | 10.04B | 10.71B | 11.89B | 12.9B | 13.73B | 12.83B | 12.16B | 12.23B | 11.12B | 10.28B |
EBIT | 7.18B | 8B | 8.49B | 8.88B | 8.67B | 8.47B | 7.98B | 7.62B | 7.46B | 7.18B | 7.19B | 7.36B | 6.82B | 6.81B | 7.46B | 8.62B | 9.55B | 10.35B | 9.4B | 8.62B | 8.71B | 7.64B | 6.85B |
Depreciation & Amortization | 2.54B | 3.33B | 3.09B | 3.12B | 3.13B | 3.14B | 3.17B | 3.22B | 3.22B | 3.25B | 3.24B | 3.24B | 3.24B | 3.23B | 3.25B | 3.27B | 3.34B | 3.38B | 3.43B | 3.54B | 3.52B | 3.48B | 3.43B |
Add to Watchlist
Select watchlists to add or remove ABT